Enveric Biosciences announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 12 pre-split shares. The reverse stock split will become effective at 8:00 a.m., New York time, on Tuesday, October 28. Enveric’s common stock will continue to be traded on the Nasdaq Capital Market under the symbol (ENVB) and will begin trading on a split-adjusted basis when the market opens on Tuesday, October 28.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENVB:
- Psychedelic: Needham initiates coverage of atai, GH Research, MindMed
- Enveric Biosciences issued patent for neuroplastogenic novel compounds
- Enveric hires firm to contest post-grant review petition filed by Gilgamesh
- Enveric Biosciences to explore digital asset treasury strategy opportunities
- Psychedelic: Enveric announces EB-003 manufacturing milestones